Navigation Links
Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
Date:9/18/2008

e relevant to use of HUMIRA in psoriasis patents," said Kim Papp, M.D., of Probity Medical Research in Waterloo, Ontario Canada.

A separate analysis of REVEAL evaluated whether specific patient characteristics would affect the efficacy of HUMIRA therapy. This second sub-group analysis found that HUMIRA effectively treats adults with psoriasis regardless of a patient's age, disease duration, whether the patient has a diagnosis of psoriatic arthritis (PsA), or if he or she has a recent history of systemic therapy, including biologic treatments. At 16 weeks, 71 percent of patients treated with HUMIRA achieved a PASI 75 response, compared with 6.5 percent of patients treated with placebo, with similar results seen among the patient subgroups.

Percentages of HUMIRA patients in subgroups who achieved PASI 75 at 16 weeks:

* Age (mean age = 44.5 years)

o 74 percent of patients 18-39 years

o 70 percent ages 40-64 years

o 61 percent age 65 and older

* Psoriasis duration (mean duration = 18.2 years)

o 68 percent diagnosed between 0.5-9.7 years

o 67 percent 9.7 - 15.9 years

o 82 percent 15.9 - 24.8 years

o 73 percent 24.8 - 65 years

* PsA diagnosis

o 70 percent of patients with a medical history of PsA

* Prior systemic treatment

o 78 percent of patients with recent history of systemic biologic

treatment (non-anti-TNF)

o 68 percent of patients with recent history of non-biologic

treatment

"These results are very reassuring for dermatologists and are important because they demonstrate that HUMIRA is a treatment option that is effective in a variety of patients with moderate to severe psoriasis," said Alan Menter, M.D., Baylor University Medical Center.

"These studies pertain to the efficacy of HUMIRA and provide further ev
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
2. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
3. Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
4. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
5. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
6. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
7. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
8. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
9. S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
10. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
11. Keraderm to Release $100 Phototherapy Treatment for Fungal Nail Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 05, 2015 Research and ... the addition of the "Clinical Laboratory,Molecular Diagnostics ... 2015 to 2019 - Latin America, Africa and ... A market that just keeps on ... benefit from the explosion in biotechnology, especially genomics. ...
(Date:5/5/2015)... May 5, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... a randomized, double-blinded, placebo-controlled Phase 2 clinical trial ... ErbB3, in combination with nab-paclitaxel and gemcitabine, versus ... metastatic pancreatic cancer who have high serum levels ... the fourth leading cause of cancer death in ...
(Date:5/5/2015)... , May 5, 2015 The ... announced the recipient of its 6 th ... Volkmer, President and CEO of Ear Professionals International ... of hearing benefits in the nation, EPIC Hearing ... contracts with managed care organizations, employers, health plans, ...
Breaking Medicine Technology:Latin America, Africa and Middle East Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 2Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 3Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 4EPIC Hearing Healthcare CEO Brad Volkmer Awarded 6th Annual Most Influential In Specialty Health 2
... CHICAGO , July 7 ... intellectual property brokerage division of ICAP plc (IAP.L), ... to the advanced drug formulation technology Captisol® owned ... US-issued patents and fifteen related foreign counterparts covering ...
... NEW YORK , July 7 Reportlinker.com announces that ... , , ... Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need ... , , ...
Cached Medicine Technology:ICAP Ocean Tomo Offers for Sale Advanced Drug Formulation Technology From CyDex Pharmaceuticals Inc. 2ICAP Ocean Tomo Offers for Sale Advanced Drug Formulation Technology From CyDex Pharmaceuticals Inc. 3Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 2Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 3Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 4Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 5Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 6Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 7Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 8Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 9Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 10Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 11Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity 12
(Date:5/5/2015)... San Rafael, CA (PRWEB) May 05, 2015 ... Snader in 2012, with the belief that ultimate Frisbee™ ... can be the next sport that engages the world. ... the youth level, by creating opportunities for young athletes ... makes this collaboration with MLU the perfect fit. , ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 NovaSom, Inc., ... upcoming episode of Innovations with Ed Begley Jr., airing ... times TBA. , This segment will focus on NovaSom, ... Viewers will learn about their AccuSom® home sleep test, ... that provides continuous patient support and next-day test results ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Every year, news ... seasons. Turns out, the worst dry eye season is spring, ... spikes in most of the United States. The only season ... water advocate Sharon Kleyne, host of the Sharon Kleyne Hour™ ... on her radio show of May 11, 2015. Kleyne is ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 McMunn ... and end-to-end automation solutions, announced today that it has ... and corporate identity. According to president and founder, Larry ... aligned with the company’s strategy for growth and expansion ... successful for the past 30 years by building close, ...
(Date:5/5/2015)... BioFit Engineered Products , a globally ... from its two latest lines at NeoCon 2015, June ... Headlining the company’s exhibit will be new Pro and ... well as the unveiling of the fifth model of ... Metzger will deliver in-booth presentations each day of the ...
Breaking Medicine News(10 mins):Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3Health News:McMunn Associates Launches New Corporate Branding with New Website 2Health News:BioFit to Introduce New Models from Latest Specialized Ergonomic Seating Lines at NeoCon 2015 2Health News:BioFit to Introduce New Models from Latest Specialized Ergonomic Seating Lines at NeoCon 2015 3
... D. Eilers Professor of Medicine and Health Care Management and ... the Wharton School, was presented with the Alpha Omega Alpha ... of Medical Colleges (AAMC). The award was presented on ... Recognizing Dr. Asch, the AAMC said, "Dr. ...
... don,t help those with existing disease , TUESDAY, Nov. ... from a young age might prevent early signs of ... study in mice. , Recent research suggests that the ... in the development of Alzheimer,s. In the new study, ...
... ... Dr Cheryl Effron of Cosmetic Dermatology of Orange County offers Sculptra Aesthetic@ at affordable ... (PRWEB) ... of Cosmetic Dermatology of Orange County offers Sculptra Aesthetic@ at affordable prices., , , ...
... ... to have policyholders select and pay extra for either a plan which covers abortion or ... ... over abortion coverage and the possibility that the same thing could happen again in the ...
... ... a North American company, is expanding its cutting edge vibration exercise technology into South ... the Pro Elite, Air Reflex and Contour Plus, are now available in South America. ... (Vocus) November ...
... ATLANTA Emory University Rollins School of Public Health ... topics at the American Public Health Association,s annual meeting ... national recommendations that a physician screen chest pain patients ... Department (ED). Additional public health research findings from ...
Cached Medicine News:Health News:David A. Asch, M.D., M.B.A., receives AAMC Distinguished Teacher Award 2Health News:FDA-Approved Sculptra@ Now Offers by Orange County Dermatologist Dr. Cheryl Effron 2Health News:“Think Outside the Box” Blog Proposes Better Abortion Compromise for Health Reform 2Health News:WAVE's Revolutionary Whole-Body Advanced Vibration Exercise Is Now Available in South America 2Health News:Some chest pain patients wait longer than 10 minutes to see ER physician 2
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
Inquire...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: